Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 20;17(2):104-108.
doi: 10.17305/bjbms.2017.1750.

High Ki-67 expression is associated with prolactin secreting pituitary adenomas

Bogdan Bălinişteanu  1 , Anca Maria Cîmpean, Amalia Raluca Ceauşu, Ana Silvia Corlan, Eugen Melnic, Marius Raica
Affiliations

High Ki-67 expression is associated with prolactin secreting pituitary adenomas

Bogdan Bălinişteanu et al. Bosn J Basic Med Sci. .

Abstract

Pituitary adenomas represent the third most common primary intracranial tumor in neurosurgical practice. To understand the biological behaviour of the pituitary adenomas previous studies have determined the tumor proliferation rate using monoclonal antibodies targeted against the Ki-67 antigen. The aim of this study was to correlate the Ki-67 index with hormonal profiles of pituitary adenomas. The study included 50 pituitary adenomas. For histopathologic evaluation, the sections were stained with routine hematoxylin and eosin method. Additional paraffin sections from each tumor were immunostained using primary antibodies against the following pituitary hormones: somatotropin (STH), prolactin (PRL), adrenocorticotrophic hormone (ACTH), thyroid-stimulating hormone (TSH), follicle-stimulating hormone (FSH), and luteinizing hormone (LH). To detect the expression of Ki-67 we used a mouse anti-human monoclonal antibody (clone K2). The percentage of Ki-67 positive nuclei (Ki-67 labeling index) was assessed by counting approximately 1000 nuclei of the tumor cells at ×400 magnification. Out of the 50 tumor samples, 31 (62%) pituitary adenomas showed proliferative activity, and the proliferation rate was variable in this group. The overall mean Ki-67 labeling index was 1.59 ± 1.47, ranging from 0.3% to 6.6%. In 5 cases, the Ki-67 index was >3%, all of them being prolactinomas. The Ki-67 index was higher in PRL-secreting adenomas (mean ± SD was 3.37 ± 1.80, range 0.9 - 6.6%). Our study provides the evidence that a higher Ki-67 value is associated with pituitary adenomas that secrete PRL (prolactinomas and mixed STH/PRL-secreting adenomas).

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Histopathological features of pituitary adenomas: (A) solid pattern (B) trabecular pattern (C) mixed pattern (D) papillary pattern (Hematoxylin and eosin staining, magnification ×20).
FIGURE 2
FIGURE 2
Cytoplasmic immunoreactivity for prolactin in pituitary adenoma samples (magnification ×40).
FIGURE 3
FIGURE 3
Immunostaining for Ki-67 antigen in pituitary adenoma samples. (A) Null cell adenoma (0% Ki-67 expression); (B) Prolactin (PRL)-secreting adenoma with 4.3% of Ki-67 expression; (C) PRL-secreting adenoma with 4.5% expression of Ki-67; (D) PRL-secreting adenoma with 6.6% expression of Ki-67.
See this image and copyright information in PMC

References

    1. Buurman H, Saeger W. Subclinical adenomas in postmortem pituitaries: Classification and correlations to clinical data. Eur J Endocrinol. 2006;154(5):753–8. https://doi.org/10.1530/eje.1.02107. - PubMed
    1. Kontogeorgos G. Predictive markers of pituitary adenoma behavior. Neuroendocrinology. 2006;83(3-4):179–88. https://doi.org/10.1159/000095526. - PubMed
    1. Lloyd RV, Kovacs K, Young WF, Jr, Farell WE, Asa SL, Trouillas J, et al. Tumors of the pituitary. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. Pathology and genetics of tumours of endocrine organs. France, Lyon: IARC Press; 2004. pp. 159–61.
    1. Al-Shraim M, Asa SL. The 2004 World Health Organization classification of pituitary tumors: What is new? Acta Neuropathol. 2006;111(1):1–7. https://doi.org/10.1007/s00401-005-1093-6. - PubMed
    1. Ragel BT, Couldwell WT. Pituitary carcinoma: A review of the literature. Neurosurg Focus. 2004;16(4):E7. https://doi.org/10.3171/foc.2004.16.4.8. - PubMed